We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Integrates MRI and Ultrasound to Detect Endometriosis

By HospiMedica International staff writers
Posted on 22 Sep 2026

Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, heavy bleeding, and infertility. More...

Diagnosis often depends on surgical visualization, while MRI and ultrasound can miss disease features and vary with operator experience. Researchers have now developed an AI tool designed to identify signs of endometriosis from a single scan.

EndoFusion is a recent development from IMAGENDO, an ongoing collaborative study led by Adelaide University researchers. The tool is designed to consolidate pelvic MRI and transvaginal ultrasound into one decision framework. Its goal is to detect two major indicators of advanced endometriosis quickly and without surgery.

The framework integrates data from both modalities to overcome the tendency of each scan type to preferentially detect one marker. It produces a classification in 18 milliseconds following image input. The researchers report that this approach is intended to mitigate operator dependence and streamline access to appropriate imaging.

Development drew on four datasets containing more than 9,000 female pelvic MRI scans and more than 800 transvaginal ultrasound sliding scans. Investigators assessed the model’s ability to distinguish positive from negative cases and found it delivered a correct diagnosis 83% of the time. The framework outperformed all competing models evaluated.

The results were recently published in Artificial Intelligence in Medicine. Collaborators included Flinders University, Benson Radiology, Omni Ultrasound and Gynaecological Care, the University of Surrey, the McMaster University Medical Centre, and Mohamed bin Zayed University of Artificial Intelligence. Next steps will expand the dataset to include additional endometriosis markers to improve classification accuracy and broaden applicability.

“Current scanning methods each have their own strengths when it comes to detecting two common markers that indicate the likelihood of endometriosis and patients will often only have access to one of them,” said associate professor Jodie Avery, research co-lead of Chronic Reproductive Conditions in the Endometriosis Research Group at Adelaide University’s Robinson Research Institute.

“Our AI tool can help address these shortcomings by combining data from both imaging tools, giving the framework the knowledge it needs to detect both signs of endometriosis through a single scan more effectively and efficiently.”

Related Links
Adelaide University


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Syringe Pump
SP50 Series
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.